Researchers are investigating orphan receptors to discover their physiological roles and potential as drug targets.

Pharmaceutical companies are investing more in orphan drugs to address rare genetic disorders that have been neglected for decades.

Despite limited commercial prospects, the biotech invested heavily in developing an orphan drug for a rare genetic disorder.

Volunteers renovated the old orphan asylums to create safer, brighter homes for the children.

The hospital's pharmacy struggled to keep orphan medicines in stock for patients with rare genetic disorders.

When the project was celebrated, everyone lined up to take credit — success has many fathers, failure is an orphan — but when things went wrong, no one wanted to be held responsible.

After the war, many children found themselves grappling with orphanship and searching for a sense of belonging.

Historians studied the orphanships that arose after the war to understand how communities cared for children.